

Artificial Heart Stent Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Artificial Heart Stent market is projected to reach $XX billion by 2027, with a CAGR of XX%. Increasing prevalence of cardiovascular diseases and advancements in medical technology are driving market growth. Rising adoption of minimally invasive procedures and growing geriatric population are key factors contributing to market expansion.
◍ Medtronic
◍ Boston Scientific
◍ Biosensors
◍ Terumo
◍ MicroPort
◍ Lepu Medical
◍ B.Braun
◍ Atrium Medical
◍ SINOMED
◍ LBC
◍ Essen Technology
The artificial heart stent market is highly competitive with key players such as Medtronic, Boston Scientific, Biosensors, Terumo, MicroPort, Lepu Medical, B.Braun, Atrium Medical, SINOMED, LBC, and Essen Technology. These companies develop, manufacture, and distribute artificial heart stents to hospitals and healthcare providers, contributing to the growth of the market.
- Medtronic: $30.12 billion
- Boston Scientific: $9.86 billion
- B.Braun: $7.25 billion
Request Sample Report
◍ Acute Myocardial Infarction
◍ Unstable Angina
◍ Angina Pectoris
◍ Bare-metal Stent (BMS)
◍ Drug-eluting Stent (DES)
◍ Bioresorbable Vascular Scaffold (BVS)
Request Sample Report
Request Sample Report
$ 3.70 Billion